Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

36.79

+0.01 (0.03%)

At close: May 27, 2026, 4:00 PM EDT

37.34

+0.55 (1.49%)

After-hours: May 27, 2026, 6:02 PM EDT

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,879	4,449	4,751	2,426	986	1,352
Market Cap Growth	34.97%	-6.36%	95.88%	146.02%	-27.09%	190.40%
Enterprise Value	2,636	3,463	3,442	1,915	653.55	1,022
Last Close Price	36.79	46.55	51.13	35.58	18.30	28.41
PS Ratio	214.69	578.10	4572.96	604.45	208.14	1254.39
PB Ratio	3.03	4.48	3.59	4.50	3.12	4.07
P/TBV Ratio	2.78	4.41	3.12	3.83	3.01	3.29
EV/Sales Ratio	145.87	450.00	3312.62	477.12	137.97	947.68
Debt / Equity Ratio	0.03	0.04	0.03	0.09	0.01	0.01
Net Debt / Equity Ratio	-0.97	-0.99	-0.98	-0.94	-1.05	-1.00
Net Debt / EBITDA Ratio	2.30	1.91	3.88	2.29	1.99	3.10
Net Debt / FCF Ratio	2.96	2.55	5.57	2.93	2.84	3.71
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.00
Inventory Turnover	0.50	1.06	-	-	-	-
Quick Ratio	18.25	12.09	22.69	12.71	12.06	20.86
Current Ratio	18.60	12.32	23.04	13.07	12.45	21.55
Return on Equity (ROE)	-43.68%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-43.20%	-40.37%	-32.74%	-45.08%	-47.75%	-40.30%
Return on Invested Capital (ROIC)	-1611.64%	-2019.92%	-978.61%	-1373.95%	7581.03%	-4172.07%
Return on Capital Employed (ROCE)	-46.03%	-42.78%	-34.47%	-48.61%	-50.91%	-42.40%
Buyback Yield / Dilution	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%
Total Shareholder Return	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q